Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein - PubMed (original) (raw)
Affiliations
- PMID: 10191295
Free article
Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein
C Wolfrum et al. J Lipid Res. 1999 Apr.
Free article
Abstract
Branched-chain phytanic acid is metabolized in liver peroxisomes. Sterol carrier protein 2/sterol carrier protein x (SCP2/SCPx) knockout mice, which develop a phenotype with a deficiency in phytanic acid degradation, accumulate dramatically high concentrations of this fatty acid in serum (Seedorf at al. 1998. Genes Dev. 12: 1189-1201) and liver. Concomitantly, a 6.9-fold induction of liver fatty acid binding protein (L-FABP) expression is observed in comparison to wild-type animals fed standard chow, possibly mediated by the peroxisome proliferator-activated receptor alpha (PPARalpha). Cytosolic transport of phytanic acid to either peroxisomal membranes or to the nucleus for activation of PPARalpha may be mediated by L-FABP, which gives rise to the question whether phytanic acid is a transactivator of this protein. Here we show first that phytanic acid binds to recombinant L-FABP with high affinity. Then the increase of the in vivo phytanic acid concentration by phytol feeding to mice results in a 4-fold induction of L-FABP expression in liver, which is in the order of that attained with bezafibrate, a known peroxisome proliferator. Finally to test in vitro whether this induction is conferred by phytanic acid, we cotransfected HepG2 cells with an expression plasmid for murine PPARalpha and a CAT-reporter gene with 176 bp of the murine L-FABP promoter, containing the peroxisome proliferator responsive element (PPRE). After incubation with phytanic acid, we observed a 3.2-fold induction of CAT expression. These findings, both in vivo and in vitro, demonstrate that phytanic acid is a transcriptional activator of L-FABP expression and that this effect is mediated via PPARalpha.
Similar articles
- Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice.
Ellinghaus P, Wolfrum C, Assmann G, Spener F, Seedorf U. Ellinghaus P, et al. J Biol Chem. 1999 Jan 29;274(5):2766-72. doi: 10.1074/jbc.274.5.2766. J Biol Chem. 1999. PMID: 9915808 - Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus.
Wolfrum C, Borrmann CM, Borchers T, Spener F. Wolfrum C, et al. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2323-8. doi: 10.1073/pnas.051619898. Epub 2001 Feb 20. Proc Natl Acad Sci U S A. 2001. PMID: 11226238 Free PMC article. - Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine.
Poirier H, Niot I, Monnot MC, Braissant O, Meunier-Durmort C, Costet P, Pineau T, Wahli W, Willson TM, Besnard P. Poirier H, et al. Biochem J. 2001 Apr 15;355(Pt 2):481-8. doi: 10.1042/0264-6021:3550481. Biochem J. 2001. PMID: 11284737 Free PMC article. - Phytanic acid: production from phytol, its breakdown and role in human disease.
van den Brink DM, Wanders RJ. van den Brink DM, et al. Cell Mol Life Sci. 2006 Aug;63(15):1752-65. doi: 10.1007/s00018-005-5463-y. Cell Mol Life Sci. 2006. PMID: 16799769 Free PMC article. Review. - Phytol and its metabolites phytanic and pristanic acids for risk of cancer: current evidence and future directions.
Bobe G, Zhang Z, Kopp R, Garzotto M, Shannon J, Takata Y. Bobe G, et al. Eur J Cancer Prev. 2020 Mar;29(2):191-200. doi: 10.1097/CEJ.0000000000000534. Eur J Cancer Prev. 2020. PMID: 31436750 Free PMC article. Review.
Cited by
- Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction.
Kamijo-Ikemori A, Sugaya T, Obama A, Hiroi J, Miura H, Watanabe M, Kumai T, Ohtani-Kaneko R, Hirata K, Kimura K. Kamijo-Ikemori A, et al. Am J Pathol. 2006 Oct;169(4):1107-17. doi: 10.2353/ajpath.2006.060131. Am J Pathol. 2006. PMID: 17003471 Free PMC article. - Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein.
Wu YL, Peng XE, Zhu YB, Yan XL, Chen WN, Lin X. Wu YL, et al. J Virol. 2015 Dec 4;90(4):1729-40. doi: 10.1128/JVI.02604-15. Print 2016 Feb 15. J Virol. 2015. PMID: 26637457 Free PMC article. - From Congenital Disorders of Fat Malabsorption to Understanding Intra-Enterocyte Mechanisms Behind Chylomicron Assembly and Secretion.
Levy E, Beaulieu JF, Spahis S. Levy E, et al. Front Physiol. 2021 Jan 27;12:629222. doi: 10.3389/fphys.2021.629222. eCollection 2021. Front Physiol. 2021. PMID: 33584351 Free PMC article. Review. - Solution structure and backbone dynamics of human epidermal-type fatty acid-binding protein (E-FABP).
Gutiérrez-González LH, Ludwig C, Hohoff C, Rademacher M, Hanhoff T, Rüterjans H, Spener F, Lücke C. Gutiérrez-González LH, et al. Biochem J. 2002 Jun 15;364(Pt 3):725-37. doi: 10.1042/BJ20020039. Biochem J. 2002. PMID: 12049637 Free PMC article. - Liver fatty acid-binding protein and obesity.
Atshaves BP, Martin GG, Hostetler HA, McIntosh AL, Kier AB, Schroeder F. Atshaves BP, et al. J Nutr Biochem. 2010 Nov;21(11):1015-32. doi: 10.1016/j.jnutbio.2010.01.005. J Nutr Biochem. 2010. PMID: 20537520 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous